Navigation Links
Prospect Therapeutics, Inc. Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors
Date:5/12/2009

WELLESLEY HILLS, Mass., May 12 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that assets of Prospect Therapeutics, Inc. ("Prospect") have been assigned to him for the benefit of Prospect's creditors.

Prospect's lead product candidate, GCS-100, is a carbohydrate molecule designed to inhibit the activity of galectin-3, a protein found in high concentration in a broad range of human cancers and whose over-expression is associated with poor prognosis in cancer patients. It is presently in Phase 2 clinical trials. The intellectual property, regulatory dossier, fixed assets and clinical inventory will be sold at auction on Monday, June 29, 2009 at 12:00 noon.

Persons interested in bidding must sign a Confidentiality Agreement ("CA") obtained from Finn's Office - jffinnjr@earthlink.net or 781-237-8840. They will then receive a bid package.

About Joseph F. Finn, Jr., C.P.A.

Joseph F. Finn, Jr., C.P.A. is the founding partner of the firm, Finn, Warnke & Gayton, Certified Public Accountants of Wellesley Hills, Massachusetts. He works primarily in the area of management consulting for distressed enterprises, bankruptcy accounting and related matters, such as assignee for the benefit of creditors and liquidating agent for a corporation. He has been involved in a number of loan workouts and bankruptcy cases for thirty-five (35) years. His most recent Assignment for the Benefit of Creditors in the biotech field was Spherics, Inc. and ActivBiotics, Inc.

For further information, please contact Joseph F. Finn, Jr., C.P.A. at 781-237-8840 or jffinnjr@earthlink.net'/>"/>

SOURCE Joseph F. Finn, Jr., C.P.A.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Publication of Supplementary Prospectus
2. Pro Football Prospects Training at TEST Sports Clubs(TM) Use SURGEX(TM) as Part of Their Pre-Combine Training Regime
3. Cell Therapeutics, Inc. Announces Authorization to Publish Italian Listing Prospectus
4. Cell Therapeutics, Inc. (CTI) to Report 2009 First Quarter Financial Results on May 7
5. Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
6. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $15 Million of Preferred Stock
7. Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry
8. Stockholder Suits Related to TorreyPines Therapeutics, Inc. Dismissed
9. Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
10. Oxygen Biotherapeutics, Inc. Adds Oxycyte TBI Clinical Trial Sites in Israel
11. Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...man . , Whether it,s CD packaging, container...ncy Identification) are increasingly finding their...label objects or goods and identify them automatic...an read and process the data contained in the labe...uction conditions of up to 100 degrees Celsius. Bu...
(Date:11/24/2009)...rk investment bank KTA Capital,s client Neuren Pha...l convertible note private placement with a U.S. i...rranged by KTA Capital as Neuren,s exclusive place... New York (PRWEB) November 23, 2009 -- The indepen...uot;KTA Capital") has announced that its clie...
(Date:11/24/2009)...IK, Iceland, November 24 ...nced that it has received notice from,the Nasdaq S...tock will be,suspended as of November 30, 2009 and...nd Exchange Commission, which will remove deCODE,s...ompany files an appeal to the Nasdaq,Listing Quali...
(Date:11/24/2009)...IK, Iceland, November 24 ...nced the approval of all of its,"first day" motion... Delaware,(the "Bankruptcy Court"). deCODE last we...pter 11 of the United States Bankruptcy Code with ... by the Bankruptcy Court allow the company to cont...
Breaking Biology Technology:Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
... , , , , , , In April, 198...California mountain road and changed the course of... conceived the Polymerase Chain Reaction (PCR).,... , , , As is shown in the figure, the...s that hybridize to opposite strands and flank ,...
... , , , , for prevention of car...44 646 100 units , Cat. No. 1 269 062 25... Description , , , Uracil-DNA Glycosyl...uracil , from single- and double-stranded D... of dUTP. The apyriminic sites formed by UNG ar...
... , , , , for amplification of up t... 314 200 reactions , , , , ,..., 2x concentrated High Fidelity PCR Master contain...tides and enzymes) needed for PCR. The mix contain...rase and Pwo DNA Polymerase[a thermostable , ...
Other Biology Technology:PCR principles 2PCR principles 3PCR principles 4Uracil-DNA Glycosylase 2High Fidelity PCR Master 2
(Date:11/25/2009)...cers and ambulance workers faced a terrifying resc...battled to save people from the collapsing Twin To...acuated as many people as they could in an area wh...ng their jobs even harder was the problem of poor ...ives jammed mobile networks with calls and the eme...
(Date:11/25/2009)...e linchpin of the environment, where atmosphere, b... students see soil as "just dirt" a place to grow...are challenged with the task of helping students a... soil in the environment. , A collaborative pro... University of Nebraska-Lincoln, Oregon State Univ...
(Date:11/25/2009)...sors recently received funding from the National S...icial to understanding the environment. The three ...assistant professor in the Department of Biologica...rate research projects. , His first project, tit...Functions from the Leaf to the Landscape," will ex...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3It's not just dirt! 2Kent State University professors focus research on the environment with grants totaling $890,000 2MarketsandMarkets 3A Global Autoimmune Treatment Market Worth US 2468 81 Billion by 2014 13750 1MarketsandMarkets 3A Global Autoimmune Treatment Market Worth US 2468 81 Billion by 2014 13750 2MarketsandMarkets 3A Global Autoimmune Treatment Market Worth US 2468 81 Billion by 2014 13750 3MarketsandMarkets 3A Global Autoimmune Treatment Market Worth US 2468 81 Billion by 2014 13750 4New hope for heart failure patients 55802 1New hope for heart failure patients 55802 2Derris Indica is CJP 26apos 3Bs New Nonfood Biodiesel Crop for Profitable Sustainability 13746 1Derris Indica is CJP 26apos 3Bs New Nonfood Biodiesel Crop for Profitable Sustainability 13746 2Derris Indica is CJP 26apos 3Bs New Nonfood Biodiesel Crop for Profitable Sustainability 13746 3
... Singapore scientists, led by Christopher Wong, Ph...e complete sequence of any influenza A virus, incl...pharyngeal wash from patients. , The new method,...of influenza A viruses and sequence them within a ...apore (GIS), one of the research institutes sponso...
...niversity at Buffalo researchers have demonstrated...ow stem cells into skeletal muscle can repair card...animal model, the researchers showed that this non...ells, by two-fold and reduced cardiac tissue injur...ion of the left ventricle, the primary pumping cha...
...am of scientists has cracked the problem of pod sh...ust before harvest, oilseed rape pods are prone to... 70% in some cases. , "By artificially producing ...ve stopped the fruit opening in the related model ...inside," says Dr Lars stergaard from the John Inne...
Other Biology News:Rapid approach to identify influenza A virus mutations and drug resistance developed 2Adult bone marrow stem cells injected into skeletal muscle can repair heart tissue 2Adult bone marrow stem cells injected into skeletal muscle can repair heart tissue 3Shatter-resistant brassicas 2
Mimic Sf9 Insect Cells from Invitrogen
Propidium iodide; solution (Available only in the U.S.) from Roche Applied Science
...lies, for 10 chips, provides the reagents and supp...alysis (picogram levels) with 10 chips on the Expe...e 1,250 microliters RNA gel, 20 microliters RNA Hi...liters RNA HighSens loading buffer, 100 microliter...
Mouse Anti-Human Non-SMC condensin II complex, subunit D3 (NCAPD3) Monoclonal Antibody, Unconjugated from Lifespan Biosciences
Biology Products: